Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Gastrointestinal Therapeutics Market, by Type
1.4.2 Europe Gastrointestinal Therapeutics Market, by Distribution Channel
1.4.3 Europe Gastrointestinal Therapeutics Market, by Route of Administration
1.4.4 Europe Gastrointestinal Therapeutics Market, by Application
1.4.5 Europe Gastrointestinal Therapeutics Market, by Drug Class
1.4.6 Europe Gastrointestinal Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Gastrointestinal Therapeutics Market
Chapter 4. Europe Gastrointestinal Therapeutics Market by Type
4.1 Europe Branded Market by Country
4.2 Europe Generics Market by Country
Chapter 5. Europe Gastrointestinal Therapeutics Market by Distribution Channel
5.1 Europe Retail Pharmacies Market by Country
5.2 Europe Hospital Pharmacies Market by Country
5.3 Europe Online Pharmacies Market by Country
Chapter 6. Europe Gastrointestinal Therapeutics Market by Route of Administration
6.1 Europe Injectable Market by Country
6.2 Europe Oral & Others Market by Country
Chapter 7. Europe Gastrointestinal Therapeutics Market by Application
7.1 Europe Crohn's Disease Market by Country
7.2 Europe Ulcerative Colitis Market by Country
7.3 Europe GERD Market by Country
7.4 Europe IBS Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Gastrointestinal Therapeutics Market by Drug Class
8.1 Europe Biologics/Biosimilar Market by Country
8.2 Europe Anti-Diarrheal Market by Country
8.3 Europe Anti-Emetics Market by Country
8.4 Europe Digestive Enzymes Market by Country
8.5 Europe Aminosalicylates Market by Country
8.6 Europe Proton Pump Inhibitors Market by Country
8.7 Europe Laxatives & H2 Antagonists Market by Country
8.8 Europe Others Market by Country
Chapter 9. Europe Gastrointestinal Therapeutics Market by Country
9.1 Germany Gastrointestinal Therapeutics Market
9.1.1 Germany Gastrointestinal Therapeutics Market by Type
9.1.2 Germany Gastrointestinal Therapeutics Market by Distribution Channel
9.1.3 Germany Gastrointestinal Therapeutics Market by Route of Administration
9.1.4 Germany Gastrointestinal Therapeutics Market by Application
9.1.5 Germany Gastrointestinal Therapeutics Market by Drug Class
9.2 UK Gastrointestinal Therapeutics Market
9.2.1 UK Gastrointestinal Therapeutics Market by Type
9.2.2 UK Gastrointestinal Therapeutics Market by Distribution Channel
9.2.3 UK Gastrointestinal Therapeutics Market by Route of Administration
9.2.4 UK Gastrointestinal Therapeutics Market by Application
9.2.5 UK Gastrointestinal Therapeutics Market by Drug Class
9.3 France Gastrointestinal Therapeutics Market
9.3.1 France Gastrointestinal Therapeutics Market by Type
9.3.2 France Gastrointestinal Therapeutics Market by Distribution Channel
9.3.3 France Gastrointestinal Therapeutics Market by Route of Administration
9.3.4 France Gastrointestinal Therapeutics Market by Application
9.3.5 France Gastrointestinal Therapeutics Market by Drug Class
9.4 Russia Gastrointestinal Therapeutics Market
9.4.1 Russia Gastrointestinal Therapeutics Market by Type
9.4.2 Russia Gastrointestinal Therapeutics Market by Distribution Channel
9.4.3 Russia Gastrointestinal Therapeutics Market by Route of Administration
9.4.4 Russia Gastrointestinal Therapeutics Market by Application
9.4.5 Russia Gastrointestinal Therapeutics Market by Drug Class
9.5 Spain Gastrointestinal Therapeutics Market
9.5.1 Spain Gastrointestinal Therapeutics Market by Type
9.5.2 Spain Gastrointestinal Therapeutics Market by Distribution Channel
9.5.3 Spain Gastrointestinal Therapeutics Market by Route of Administration
9.5.4 Spain Gastrointestinal Therapeutics Market by Application
9.5.5 Spain Gastrointestinal Therapeutics Market by Drug Class
9.6 Italy Gastrointestinal Therapeutics Market
9.6.1 Italy Gastrointestinal Therapeutics Market by Type
9.6.2 Italy Gastrointestinal Therapeutics Market by Distribution Channel
9.6.3 Italy Gastrointestinal Therapeutics Market by Route of Administration
9.6.4 Italy Gastrointestinal Therapeutics Market by Application
9.6.5 Italy Gastrointestinal Therapeutics Market by Drug Class
9.7 Rest of Europe Gastrointestinal Therapeutics Market
9.7.1 Rest of Europe Gastrointestinal Therapeutics Market by Type
9.7.2 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel
9.7.3 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration
9.7.4 Rest of Europe Gastrointestinal Therapeutics Market by Application
9.7.5 Rest of Europe Gastrointestinal Therapeutics Market by Drug Class
Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 AbbVie, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Approvals and Trials:
10.3 Takeda Pharmaceutical Company Limited
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisition and Mergers:
10.4 Pfizer, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.5 Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Product Launches and Product Expansions:
10.6 Johnson & Johnson (Janssen Global Services, LLC)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental &Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 AstraZeneca PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.8 Bayer AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 Sun Pharmaceutical Industries Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Research & Development Expenses
10.10. Cipla Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
Unique Offerings 
